Interest of Eye Movement Measurements in the Comprehension of Dry Eyes Symptoms
- Conditions
- Dry Eye SyndromesBlinking
- Interventions
- Device: Infrared oculography
- Registration Number
- NCT02851654
- Lead Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Brief Summary
Dry eye syndrome is a benign situation however its impact on patient's quality of live and on health system is not trivial. One problem is the lack of correlation between patient's symptoms and physical sign observed on slit lamp examination. Eye blinking is a parameter of increased interest in this pathology particularly its frequency. To date no treatment of dry eye syndrome has a proven impact on eye blinking frequency. However recording of blinks has mostly been performed on short duration (3 to 5 minutes) and the distribution of intervals between 2 blinks is not gaussian but exponential. In this study, it is proposed to use modern eye-movement recorder to measure the blink frequency on longer duration (12 minutes) while reading on a screen computer and during a face-to-face interview before and after treatment of meibomian gland dysfunction responsible of moderate to severe dry eye syndrome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 24
- Moderate to severe dry eye syndrome (Ocular Surface Disease Index> 30) following a meibomian gland dysfunction
- Not yet properly treated for a meibomian gland dysfunction
- History of other ophthalmological or neurological disease
- Pregnant or breastfeeding women
- Patient under 18 years old
- Patient under legal protection
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Dry eye syndrome Infrared oculography Meibomian gland dysfunction responsible of moderate to severe dry eye syndrome
- Primary Outcome Measures
Name Time Method duration between 2 blinks 2 months after treatment Assessment by infrared oculography while the patient is reading on a computer screen and during a face-to-face interview
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Fondation Ophtalmologique Adolphe de Rothschild (FOR)
🇫🇷Paris, France